|
Match
|
Document |
Document Title |
|
|
4168313 |
Phthalidyl 2-(3'-trifluoromethyl-anilino)-pyridine-3-carboxylate and its salts
A new phthalidylic eater of 2-(3'trifluoromethyl-anilino)-pyridine-3-carboxylic acid is prepared by reacting 2-(3'-trifluoromethylanilino)-pyridine-3-carboxylic acid with 3-bromophthalide and an...
|
|
|
4160028 |
Substituted 2-cyclopropyl-chromones and pharmaceutical compositions and use thereof
Substituted 2-cyclopropylchromones, process of preparation, pharmaceutical compositions and method of treating allergies are disclosed.
|
|
|
4144345 |
Dihydroxybenzisoxazolin-3-yl-substituted-5-nitroimidazoles as antibacterials and antiprotozoals
Dihydroxybenzisoxazolin-3-yl-substituted-1-methyl-5-nitroimi
dazoles having the hydroxy- groups on adjacent 4,5-; 5,6- or 6,7-positions of the isoxazolin group. These compounds have antibacterial...
|
|
|
4113870 |
Method for treatment of hypertension
Hypertension can be treated with a nicotinate of chroman of the formula: ##STR1## WHEREIN N IS AN INTEGER OF FROM 0 TO 3, R 1 stands for ##STR2## and R 2 stands for --CH 3 or ##STR3## with the...
|
|
|
4075335 |
Pharmaceutical piperidine derivatives
Piperidines of the formula ##STR1## in which R 1 stands for optionally substituted aryl, R 2 for hydrogen, lower alkyl, lower alkenyl, acyl or α-aryl-lower alkyl, R 3 for a free or substituted...
|
|
|
4073910 |
Method for treatment of diabetes
Therapeutical treatment of diabetes by oral or parenteral administration of Vitamine E nicotinate which exhibits remarkable effects for treatment of diabetes without accompanying injurious side...
|
|
|
4053608 |
Compositions and methods for the treatment of coccidiosis
Anticoccidial compositions which comprise as active ingredient pyridine derivatives having the formula ##STR1## wherein R 1 is hydrogen atom, a halomethyl group or methyl group; R 2 is...
|
|
|
4036979 |
Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
This disclosure describes a novel method for improving feed efficiency and accelerating the growth rate of veterinary homothermic animals by administering to said animals a growth-promoting amount...
|
|
|
4032640 |
4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes
This invention provides new compounds of formula I, ##STR1## wherein R 1 is hydrogen, halogen of atomic number from 9 to 35, or alkyl or alkoxy of 1 to 4 carbon atoms, R 2 is hydrogen or alkyl...
|
|
|
4006240 |
Alcohol aversion process by enzyme inhibition
A biochemical explanation for preferential alcohol consumption is proposed involving excessive cholinergic activity in brain tissue. A process by which alcohol aversion can be induced involving...
|
|
|
3996364 |
9-Xanthylamin oalkylpyridine derivatives
9-Xanthylaminoalkylpyridine derivatives are prepared. These compounds are inhibitors of gastric acid secretion.
|
|
|
3988467 |
Aminoacyl compounds
The invention relates to new aminoacyl compounds of the formula I, ##SPC1##
|
|
|
3974280 |
Benzothiophenes
The invention relates to a process for the production of new benzo[b]thiophenes of formula I ##SPC1## wherein PH is optionally substituted o-phenylene, one of the radicals R 1 and R 2 is...
|
|
|
3974289 |
Coumarin derivatives for the treatment of allergies
Pharmaceutical compositions for the treatment of allergies are produced using coumarin derivatives as the active agent. Certain of these compounds and their salts are novel.
|
|
|
3973023 |
Anti-hypertensive polycyclic compounds for treating hypertension
Chromanols of the formula (II) ##SPC1## wherein R 1 is a non-aromatic hydrocarbon group of 1-20 carbon atoms, R 2 is a hydrocarbon group of 1-20 carbon atoms optionally substituted by a halogen...
|
|
|
3864493 |
Compositions and methods for the prevention of asthmatic symptoms
There are disclosed compositions containing a number of benzodipyrons, e.g. 4,10-dioxo-2,8-dicarboxy-5-methoxy-4H,10H-benzo(1,2-b:3,4-b'
) dipyran, and the use of these benzodipyrones in the...
|
|
|
3810991 |
A METHOD OF INDUCING FIBRINOLYSIS
Method of treating mammals to induce fibrinolysis or counteract fibrinolytic syndromes by administering a compound of the formula ##SPC1## Wherein R 1 represents a straight or branched chain alkyl...
|
|
|
3636217 |
Title is not available
|
|
|
3657439 |
Title is not available
|